Skip to main content
Top
Published in: Lung 2/2024

Open Access 18-03-2024 | Bronchiectasis | DYSPHAGIA and BRONCHIECTASIS

Asymptomatic Dysphagia and Aspiration in Patients with Idiopathic Bronchiectasis

Authors: Tal Perluk, Eiman Abu Bandora, Ophir Freund, Tommy Jacob, Inbal Friedman Regev, Eyal Kleinhendler, Michal Shteinberg, Amir Bar-Shai, Yael Oestriecher-Kedem

Published in: Lung | Issue 2/2024

Login to get access

Abstract

Purpose

Although considered contributors to idiopathic bronchiectasis (IB), neither dysphagia nor silent aspiration have been systematically evaluated in IB patients. We aimed to explore the prevalence of asymptomatic dysphagia and silent aspiration in IB patients and to identify parameters predictive of their presence.

Methods

This prospective cohort study included IB patients from our Pulmonary Institute without prior history of dysphagia and without prior dysphagia workup. Swallowing function was assessed by the Eating Assessment Tool (EAT-10) questionnaire and by the Fiberoptic Endoscopic Evaluation of Swallowing (FEES) test.

Results

Forty-seven patients (31 females, mean age 67 ± 16 years) were recruited. An EAT-10 score ≥ 3 (risk for swallowing problems) was present in 21 patients (44.6%). Forty-two patients (89.3%) had at least one abnormal swallowing parameter in the FEES test. Six patients (12.7%) had a penetration aspiration score (PAS) in the FEES of at least 6, indicating aspiration. An EAT-10 score of 3 was found to be the ideal cutoff to predict aspiration in the FEES, with a good level of accuracy (area under the curve = 0.78, 95% CI 0.629–0.932, p = 0.03) and sensitivity of 83%. This cutoff also showed a trend towards a more severe disease using the FACED (forced expiratory volume, age, colonization with pseudomonas, extension of lung involvement, dyspnea) score (p = 0.05).

Conclusion

Dysphagia is prevalent in IB and may be undiagnosed if not specifically sought. We recommend screening all patients with IB for dysphagia by the EAT-10 questionnaire and referring all those with a score of ≥ 3 to formal swallowing assessment.
Literature
3.
go back to reference Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, Soyza AD, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD (2017) European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. https://doi.org/10.1183/13993003.00629-2017CrossRefPubMed Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, Soyza AD, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD (2017) European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. https://​doi.​org/​10.​1183/​13993003.​00629-2017CrossRefPubMed
4.
go back to reference Hill AT, Sullivan AL, Chalmers JD, Soyza AD, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher WP, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR (2019) British Thoracic Society guideline for bronchiectasis in adults. Thorax 74(Suppl 1):1–69. https://doi.org/10.1136/thoraxjnl-2018-212463CrossRefPubMed Hill AT, Sullivan AL, Chalmers JD, Soyza AD, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher WP, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR (2019) British Thoracic Society guideline for bronchiectasis in adults. Thorax 74(Suppl 1):1–69. https://​doi.​org/​10.​1136/​thoraxjnl-2018-212463CrossRefPubMed
17.
go back to reference Rofes L, Arreola V, Almirall J, Cabré M, Campins L, García-Peris P, Speyer R, Clavé P (2010) Diagnosis and management of oropharyngeal dysphagia and its nutritional and respiratory complications in the elderly. Gastroenterol Res Pract 2011:e818979. https://doi.org/10.1155/2011/818979CrossRef Rofes L, Arreola V, Almirall J, Cabré M, Campins L, García-Peris P, Speyer R, Clavé P (2010) Diagnosis and management of oropharyngeal dysphagia and its nutritional and respiratory complications in the elderly. Gastroenterol Res Pract 2011:e818979. https://​doi.​org/​10.​1155/​2011/​818979CrossRef
27.
go back to reference Salik I, Doherty TM (2024) Mendelson syndrome. StatPearls. StatPearls Publishing, Treasure Island Salik I, Doherty TM (2024) Mendelson syndrome. StatPearls. StatPearls Publishing, Treasure Island
33.
go back to reference Nacci A, Ursino F, La Vela R, Matteucci F, Mallardi V, Fattori B (2008) Fiberoptic Endoscopic Evaluation of Swallowing (FEES): proposal for informed consent. Acta Otorhinolaryngol Ital 28(4):206–211PubMedPubMedCentral Nacci A, Ursino F, La Vela R, Matteucci F, Mallardi V, Fattori B (2008) Fiberoptic Endoscopic Evaluation of Swallowing (FEES): proposal for informed consent. Acta Otorhinolaryngol Ital 28(4):206–211PubMedPubMedCentral
Metadata
Title
Asymptomatic Dysphagia and Aspiration in Patients with Idiopathic Bronchiectasis
Authors
Tal Perluk
Eiman Abu Bandora
Ophir Freund
Tommy Jacob
Inbal Friedman Regev
Eyal Kleinhendler
Michal Shteinberg
Amir Bar-Shai
Yael Oestriecher-Kedem
Publication date
18-03-2024
Publisher
Springer US
Published in
Lung / Issue 2/2024
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-024-00683-5

Other articles of this Issue 2/2024

Lung 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine